Peptides DB
Research-centric peptide and protocol reference hub
Study 2 of 3Apraglutide literatureNature medicineTop journal2025

Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults.

Not reported in abstract.

Read at Nature medicineAdd to compare

Where it sits

this study against the rest of the apraglutide corpus
3
Preclinical · this one
0
Observational
0
Open-label
0
Randomised
0
Reviews

Summary and findings

Not reported in abstract.

How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2025

Abstract

The authors’ words, as Nature medicine supplied them

Respiratory syncytial virus (RSV) causes a substantial health burden among infants and older adults. Prefusion F protein-based vaccines have shown high efficacy against RSV disease in clinical trials, offering promise for mitigating this burden through maternal and older adult immunization. Employing an individual-based model, we evaluated the impact of RSV vaccination on hospitalizations and deaths in 13 high-income countries, assuming that the vaccine does not prevent infection or transmission. Using country-specific vaccine uptake rates for seasonal influenza, we found that vaccination of older adults would prevent hospitalizations by a median of 35-64% across the countries studied here. Vaccination of pregnant women could avert infant hospitalizations by 5-50%. Reductions in RSV-related mortality mirrored those estimated for hospitalizations. While substantial hospitalization costs could be averted, the impact of vaccination depends critically on uptake rates. Enhancing uptake and accessibility is crucial for maximizing the real-world impact of vaccination on reducing RSV burden among vulnerable populations.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the Apraglutide corpus

DCryo-EM structures reveal native GABA(A) receptor assemblies and pharmacology.Nature · 2023—DIs young people's mental health worse than in the past?BMJ (Clinical research ed.) · 2026—